Patents by Inventor Liming Yu

Liming Yu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for determination of apparent resistivities of anisotropic reservoirs
    Patent number: 6466872
    Abstract: Shoulder corrections are applied to measurements obtained from a multicomponent electromagnetic logging tool. An anisotropic resistivity model is obtained using the shoulder corrected data. The process is iterated until a good match is obtained between the shoulder corrected data and the model output.
    Type: Grant
    Filed: September 29, 2000
    Date of Patent: October 15, 2002
    Assignee: Baker Hughes Incorporated
    Inventors: Berthold F. Kriegshauser, Otto N. Fanini, Pravin Gupta, Liming Yu
  • Hybrid with interferon-.beta. and an immunoglobulin Fc joined by a peptide linker
    Patent number: 5908626
    Abstract: Disclosed is a hybrid recombinant protein consisting of human interferon-.beta., and a human immunoglobulin Fc fragment, preferably .gamma.4 chain, joined by a peptide linker comprising the sequence Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser (SEQ ID NO:1).
    Type: Grant
    Filed: December 19, 1997
    Date of Patent: June 1, 1999
    Assignee: Tanox, Inc.
    Inventors: Tse Wen Chang, Liming Yu
  • gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies
    Patent number: 5739306
    Abstract: Disclosed are immunogens and peptides based on the binding site of gC1q-R for HIV-1 gp120, and immunogens and peptides based on the binding site of HIV-1 gp120 for gC1q-R. The sequence of the gC1q-R binding site for gp120 is shown in SEQ ID NO.: 2. The sequence of the HIV-1 gp120 binding site for gC1q-R is shown in SEQ ID NO.: 3. Also disclosed are antibodies and binding molecules to all such immunogens and peptides, and inducing the endogenous production of such antibodies.
    Type: Grant
    Filed: September 9, 1996
    Date of Patent: April 14, 1998
    Assignee: Tanox Biosystems, Inc.
    Inventors: Michael S.C. Fung, Bill N.C. Sun, Cecily R.Y. Sun, Young Woo Kim, Liming Yu
  • gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies
    Patent number: 5731428
    Abstract: Disclosed are immunogens and peptides based on the binding site of gClq-R for HIV-1 gp120, and immunogens and peptides based on the binding site of HIV-1 gp120 for gClq-R. The sequence of the gClq-R binding site for gp120 is shown in SEQ ID NO.: 2. The sequence of the HIV-1 gp120 binding site for gClq-R is shown in SEQ ID NO.: 3. Also disclosed are antibodies and binding molecules to all such immunogens and peptides, and inducing the endogenous production of such antibodies.
    Type: Grant
    Filed: September 6, 1996
    Date of Patent: March 24, 1998
    Assignee: Tanux Biosystems, Inc.
    Inventors: Michael S. C. Fung, Bill N. C. Sun, Cecily R. Y. Sun, Young Woo Kim, Liming Yu
  • GC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies
    Patent number: 5728814
    Abstract: Disclosed are immunogens and peptides based on the binding site of gC1q-R for HIV-1 gp120, and immunogens and peptides based on the binding site of HIV-1 gp120 for gC1q-R. The sequence of the gC1q-R binding site for gp120 is shown in SEQ D NO.: 2. The sequence of the HIV-1 gp120 binding site for gC1q-R is shown in SEQ ID NO.: 3. Also disclosed are antibodies and binding molecules to all such immunogens and peptides, and inducing the endogenous production of such antibodies.
    Type: Grant
    Filed: September 4, 1996
    Date of Patent: March 17, 1998
    Assignee: Tanox Biosystems, Inc.
    Inventors: Michael S. C. Fung, Bill N. C. Sun, Cecily R. Y. Sun, Young Woo Kim, Liming Yu
  • Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
    Patent number: 5723125
    Abstract: Disclosed is a hybrid recombinant protein consisting of human interferon, preferably interferon-.alpha. (IFN.alpha.), and human immunoglobulin Fc fragment, preferably .gamma.4 chain, joined by a peptide linker comprising the sequence Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser (SEQ ID NO:1).
    Type: Grant
    Filed: September 25, 1996
    Date of Patent: March 3, 1998
    Assignee: Tanox Biosystems, Inc.
    Inventors: Tse Wen Chang, Liming Yu
  • GC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies
    Patent number: 5691447
    Abstract: Disclosed are immunogens and peptides based on the binding site of gC1q-R for HIV-1 gp120, and immunogens and peptides based on the binding site of HIV-1 gp120 for gC1q-R. The sequence of the gC1q-R binding site for gp120 is shown in SEQ ID NO.: 2. The sequence of the HIV-1 gp120 binding site for gC1q-R is shown in SEQ ID NO.: 3. Also disclosed are antibodies and binding molecules to all such immunogens and peptides, and inducing the endogenous production of such antibodies.
    Type: Grant
    Filed: March 24, 1995
    Date of Patent: November 25, 1997
    Assignee: Tanox Biosystems, Inc.
    Inventors: Michael S. C. Fung, Bill N. C. Sun, Cecily R. Y. Sun, Young Woo Kim, Liming Yu
  • gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies
    Patent number: 5652333
    Abstract: Disclosed are immunogens and peptides based on the binding site of gC1q-R for HIV-1 gp120 and immunogens and peptides based on the binding site of HIV-1 gp120 for gC1q-R. The sequence of the gC1q-R binding site for gp120 is shown in SEQ ID NO.: 2. The sequence of the HIV-1 gp120 binding site for gC1q-R is shown in SEQ ID NO.: 3. Also disclosed are antibodies and binding molecules to all such immunogens and peptides, and inducing the endogenous production of such antibodies.
    Type: Grant
    Filed: September 6, 1996
    Date of Patent: July 29, 1997
    Assignee: Tanox Biosystems, Inc.
    Inventors: Michael S. C. Fung, Bill N. C. Sun, Cecily R. Y. Sun, Young Woo Kim, Liming Yu